 Shares of Immunomedics, Inc. NASDAQ:IMMU have received a consensus rating of Hold from the fourteen ratings firms that are currently covering the stock, Marketbeat reports. Eight investment analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 12-month price target among brokers that have ... 